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Summary 
We investigated the possibility that T  helper  cells might  enhance  the  stimulatory function  of 
dendritic  cells  (DCs).  We found that ligation  of CD40  by CD40L  triggers the production  of 
extremely high levels ofbioactive IL-12. Other stimuli such as microbial agents, TNF-cx or LPS 
are much less effective or not at all. In addition,  CD40L is the most potent stimulus in upregu- 
lating the expression ofICAM-1,  CD80, and CD86 molecules on DCs. These effects of CD40 
ligation result in an increased capacity of DCs to trigger proliferative responses and IFN-~/pro- 
duction by T  cells. These findings reveal a new role for CD40-CD40L interaction in regulating 
DC function and are relevant to design therapeutic  strategies using cultured DCs. 
I 
t  is well established  that IL-12 is responsible  for the  de- 
velopment of Thl  responses  (1-3).  The identification  of 
the cells responsible for IL-12 production in vivo at the site 
ofT  cell priming is a critical issue that needs to be clarified. 
In a  series  of original  experiments  Murphy,  O'Garra,  and 
colleagues demonstrated  that bacteria such as Listeria mono- 
cytogenes  can  stimulate  macrophages  to produce  IL-12 and 
that this  cytokine  can act on bystander T  cells that recog- 
nize  antigen  on  different  APCs  (1).  Thus,  in  this  system 
IL-12 appears to function in a paracrine fashion, since IL-12 
production  and  antigen  presentation  could  be  carried  out 
by different cells. 
Dendritic  cells  (DCs)  are  professional  APCs  specialized 
in  antigen  capture,  migration  to  secondary  lymphoid  or- 
gans  and  T  cell  priming  (4-7).  In particular,  DCs  can be 
triggered by proinflammatory stimuli such as TNF-~x, IL-1, 
and LPS to mature and to upregulate adhesion and costim- 
ulatory molecules  (7, 8).  Recent reports indicate  that DCs 
can produce IL-12, but the signals involved in IL-12 stimu- 
lation have not been fully characterized  (9,  10). 
We have tested IL-12 production  by human DCs in re- 
sponse to various stimuli.  CD40L appears to be the most if 
not the only effective stimulus since it induces the produc- 
tion of massive amounts ofbioactive IL-12 in both primary 
and cultured DCs. In addition, it induces a marked upregu- 
lation of adhesion and costimulatory molecules, resulting in 
enhanced T  cell stimulatory capacity. These results suggest 
that T  cells can modulate  by cognate interaction  the  anti- 
gen-presenting function of DCs and favor the development 
ofa Thl  response. 
Materials and Methods 
Media and Reagents.  The medium used throughout was R.PMI 
1640  supplemented  with  2  mM  L-glutamine,  1% non  essential 
amino acids,  1% pyruvate, 50 I.~g/ml kanaraycin (GIBCO BRL, 
Gaithersburg, MD), 5 X  10 -5 M 2-ME (Merck, Darmstadt, Ger- 
many), and 10% FCS (Hyclone Laboratories, Logan, Utah). Hu- 
man rIL-4 and  rGM-CSF  were produced  in  our laboratory by 
PCR cloning and expression in the rayeloraa expression system 
(11). Human rTNF-o~ was a gift of Dr. W. Lesslauer  (Hoffraann- 
La Roche AG, Basel, Switzerland)  and was used at a concentra- 
tion  of 20  ng/ml.  LPS  (Salmonella  abortus-equO was  purchased 
from SEBAK (Munich,  Germany). Growth curves of Staphylococ- 
cus aureus, Pseudoroonas aeruginosa, and Candida albicans were estab- 
lished  and  cultures  stopped  in  the  logarithmic  growth  phase, 
washed twice in PBS and inactivated by incubating for 60 rain at 
60~  They were used within a range of concentrations found to 
be optimal for stimulation of IL-12 production by mouse mac- 
rophages. J558L  cells  transfected with  CD40L  were  previously 
described (12). The generation of Tetanus Toxoid-specific T  cell 
clones was previously reported (13). 
Priroary and Cultured DCs.  The method for the generation of 
DCs from peripheral blood raonocytes has been previously de- 
scribed  (14).  Briefly, PBMCs  obtained by Ficoll-Paque  method 
(Organon Teknika, Durham, NC) were either separated on raul- 
tistep  Percoll  gradients  (Pharraacia  Fine  Chemicals,  Uppsala, 
Sweden)  or  isolated  by  elutrial  centrifugation.  The  recovered 
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with anti-CD14 antibody TIB228 (IgG2b; American Type Cul- 
ture Collection, Rockville, MD), were cultured at 3 ￿  105/ml in 
R.PMI-10%  FCS  supplemented  with  50  ng/ml  GM-CSF  and 
1,000 U/ml IL-4 for 6 days. In some experiments,  primary DCs 
were isolated by serial depletion ofT cells, monocytes, NK and B 
cells, as described  (15). The purified cells were cultured for 24 h 
in RPMI-10% FCS supplemented with  either  GM-CSF+IL-4, 
GM-CSF+TNF-c~,  or GM-CSF  alone.  To induce  IL-12 pro- 
duction, 1.5 ￿  l0  s ceils were cultured in 0.5 ml P,.PMI-10% FCS 
in a 48 well plate in the presence  of  various stimuli. The superna- 
tant was collected after 40 h. 
Staining with mAbs.  Cell staining was performed using mouse 
mAbs followed by FITC-conjugated, affinity-purified,  goat anti- 
mouse  IgG  antibody  (Southern  Biotechnology,  Birmingham, 
AL). The following mAbs were used:  SPLV3  (lgG2a,  anti-DQ) 
(American Type Culture Collection); B7.24 (IgG2a, anti-CD80) 
(kindly  provided by Dr.  M.  Deboer,  Immunogenetics,  Ghent, 
Belgium); B70/B7-2 (IgG2b, anti-CD86) and HA58 (IgG1, anti- 
ICAMI) (Pharmingen,  San Diego, CA). The samples were ana- 
lyzed on a FACScan  |  (Becton Dickinson)  using propidium io- 
dide to exclude dead cells. 
Staining  for Intracellular IL-I2.  Des from GM-CSF+IL-4 cul- 
tures were cultured with CD40L-transfected cells for 14 h, fixed 
in 0.1% of glutaraldehyde  and 3.7% of formaldehyde, permeabi- 
lized in 0.2% of Triton X-100 and stained with the anti-IL-12 p40 
mAb 2-4A1 (IgG2b)  followed by FITC-conjugated second anti- 
body and counter-stained with BODIPY T1K-X phallacidin  (Mo- 
lecular Probes, Leiden, Holland).  The cells were examined  using a 
confocal microscope (MR_C 1024) (Bio-Rad, Cambridge, MA). 
Mixed Lymphocyte Reaction.  10  s responding cells either from 
an unrelated individual  (allogeneic  MLIL) or autologous PBMCs 
(autologous  MLIK) were cultured in 96-well fiat-bottom micro- 
plates  (Costar  Corp.) with different  numbers of irradiated  (3,000 
rad from a 137Cs source)  stimulator  DCs cells in the presence or 
absence  of  anti-ILl2  antibodies  20C2  (anti-p75,  IgG1)  and 
2-4A1  at  2  ~g/rnl.  Thymidine incorporation was measured on 
day 5 by a 18-h pulse with  [3H]thymidine  (1  IxCi/well, specific 
activity,  5 Ci/mMol; Amersham Life Science,  Buckinghamshire, 
UK). Before the addition of [3H]thymidine 50 txl of supernatants 
were collected to measure ",/-IFN production. 
Detection of lL-I2 and IFN-T by ELISA.  IFN-'~ was  detected 
in the supernatants  using a two-site sandwich ELISA (16); IL-12 
p75  heterodimer  and  IL-12 p40  were  measured by a  two-site 
sandwich ELISA employing clone 20C2 and clone 2-4A1 as cap- 
ture antibody, respectively;  clone 4D6-conjugated to horse radish 
peroxidase  (HP,  P) was used as second antibody (anti-ILl2 anti- 
bodies  were  kindly provided by Dr.  M.  Gately,  Hoffmann-La 
R.oche,  Inc., Nutley,  NJ)  (17). Samples were analyzed  in serial 
twofold dilutions in triplicate; the sensitivity of the assay is 50 pg/ml. 
Results 
CD40 Ligation  Is the Most Effective Stimulus Inducing IL-12 
Production by DCs.  We have  previously shown that  DCs 
can be generated after in vitro culture  of peripheral blood 
mononuclear  cells  with  GM-CSF+IL-4  (14).  These  cells 
are characterized by a very high endocytic activity and can 
respond to inflammatory stimuli such as TNF-cr  IL-1 and 
LPS by undergoing a terminal maturation which results in 
downregulation  of endocytic capacity and npregulation  of 
adhesion  and  costimulatory  molecules  (7).  Since  IL-12 
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Figure 1.  Cultured  DCs produce high levels ofbioactive IL-12 follow- 
ing stimulation by CD40L. DCs cultured in GM-CSF + lL4 were exposed 
to the indicated stimuli in the presence (dotted bars) or absence (empty bars) 
of IFN-'y. IL-12 p75 (A) and p40 (/3) were measured after 40 h. 
plays an important role in polarizing T  ceils towards Thl, it 
was important to ask whether DCs can produce IL-12 and 
to identify the  most effective stimuli  in triggering its  pro- 
duction. 
DCs generated in the presence  of GM-CSF+IL-4 were 
challenged with various stimuli  consisting of intact patho- 
gens,  LPS,  TNF-oL,  and  CD40L-transfected  ceils.  IL-12 
production was measured in the supernatants after 40 h us- 
ing specific  ELISA assays  that  detect  either  IL-12 p40  or 
the  biologically active  heterodimer  p40/p35  (IL-12 p75). 
As  shown  in  Fig.  1,  DCs  produced  massive  amounts  of 
both  p40  (up  to  120  ng/ml)  and  p75  (up  to  20  ng/ml) 
when  stimulated  by CD40L.  The  addition  of IFN--/  en- 
hanced IL-12 production in most preparations,  but only to 
a limited  extent.  Other stimuli  that have been reported to 
induce IL-12 production by murine macrophages were ei- 
ther much less  effective or ineffective at all.  These include 
LPS,  TNF-ot,  and  pathogens  such  as  Staphylococcus aureus, 
Pseudomonas aeruginosa, Candida albicans, and Leishmania major. 
IL-12 production could be visualized at a single cell level 
by staining DCs,  stimulated  for  14  h  with  CD40L-trans- 
fected cells (Fig. 2). In fixed and petrneabilized cells the IL-12 
staining was typically localized in the  Golgi apparatus,  and 
was not detected in DCs cultured with control J558L cells 
(data not shown). 
IL-12 production could be triggered also in an antigen- 
specific system.  Fig.  3  shows that a tetanus  toxoid-specific 
T  cell clone (TC),  in the presence of the relevant antigen, 
can trigger IL-12 production by antigen-presenting Des. 
To analyze whether IL-12 production is a general prop- 
erty of DCs we tested primary DCs isolated by serial deple- 
tion  of T,  monocytes, B  and  NK cells  (15).  As shown in 
Fig. 4, CD40L stimulation  (but not LPS) induced produc- 
tion of extremely high levels ofbioactive IL-12. It is note- 
worthy  that  such  a  high  IL-12  production  was  observed 
also in  cells  that  had  not been  cultured  with  IL-4, ruling 
out  the  possibility  that  the  IL-12 production  observed in 
these experiments could be due to the effect of IL-4 in the 
culture medium (18).  In contrast to DCs, fresh monocytes 
produced  very  low  levels  of IL-12  (<1  ng/ml  of IL-12 
748  Activation of Dendritic  Cells by T Lymphocytes Figure  2.  Induction  of IL-12  p40  de- 
tected at single cell level in DCs stimulated 
with  CD40L. DCs  were  stimulated with 
CD40L-transfected J558L cells and stained 
after  14  h  with the anti  IL-12  p40  mAb 
2-4A1,  followed by  FITC-labeled  second 
antibody  and  counter-stained  with  BO- 
DIPY TR-X phallacidin. More than 80% of 
DCs were positive. 
p75),  only  when  triggered  by  CD40L  and,  only  in  the 
presence of IFN-~/(data not shown). 
We  conclude  that  both  primary and  cultured DCs  can 
respond selectively to stimulation by CD40L with produc- 
tion of extremely high levels of IL-  12. 
CD40 Ligation on DCs Results in Upregulation of Adhesion 
and  Costimulatory Molecules and in Enhanced T  Ceil Stimula- 
tory Capacity.  We  have  previously shown  that  DCs  cul- 
tured in GM-CSF+IL-4  have an immature phenotype and 
can undergo phenotypic and functional changes after stim- 
ulation  with  TNF-ci,  LPS,  or  CD40L  (7).  These  stimuli 
may be actually responsible for DCs maturation in vivo and 
can be acting at different times during maturation in vivo. 
It  was  therefore  interesting  to  investigate  whether  such 
stimuli  were  equally effective in  modulating DCs  surface 
antigens and in triggering T  cell stimulatory properties. 
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IL-12 production by DCs is elicited by antigen-specific in- 
teraction with T cells. DCs were cultured with a TT-specific T cell clone 
(TC) in the presence or absence of TT.  IL-12 p40 (black bars) and p75 
(dotted bars) were measured in the culture supematants after 48 h. We ex- 
clude the T cell clone as a source oflL-12, since it did not produce IL-12 
when stimulated  by peptide presented by fixed EBV-B cells  or by PMA + 
ionomycin. 
We thus measured the level of adhesion and costimula- 
tory molecules on DCs before and after stimulation. Table 1 
shows that CD40L can dramatically increase the expression 
of ICAM-1  (up  to  six-fold the basal level), CD80  ('o10- 
fold) and especially CD86 (up to 100-fold). In addition, the 
expression  of HLA-DQ  was  increased  ~10-fold.  In  all 
cases TNF-e~ and LPS had similar effects, although less pro- 
nounced. 
DCs from GM-CSF+ IL-4 cultures were stimulated with 
CD40L,  TNF-c~  or LPS  and  compared for their stimula- 
tory capacity in  autologous and allogeneic MLR.  The  re- 
sults in Fig. 5 show that in all cases the stimulatory capacity 
of  DCs  is  dramatically  enhanced  by  these  maturation- 
inducing stimuli, the  most  effective stimulus being,  how- 
ever, CD40L.  This was particularly evident when the pro- 
duction of IFN-y was measured.  Consistent with the role 
of IL-12  in  driving  Thl  responses  (19),  the  addition  of 
anti-IL-12  antibodies  dramatically decreased  IFN-y  pro- 
duction. 
We conclude that CD40 ligation can increase the T  cell 
stimulatory capacity of DCs and favor Thl responses. 
Discussion 
We have shown that DCs can respond to stimulation via 
CD40L  by producing very high levels of bioactive IL-12 
and  upregulating  adhesion  and  costimulatory  molecules. 
Altogether these effects lead to a stronger T  cell stimulation 
and bias the T  cell response towards Thl. 
The level of IL-12 produced by cultured as well as pri- 
mary DCs is much higher than that previously reported for 
macrophages and monocytes. The fact that DCs are likely 
to  deliver IL-12  in  a  cognate  fashion  to  T  cells clustered 
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Figure  4.  IL-12  production 
by primary DCs stimulated with 
CD40L. Primary DCs were iso- 
lated and cultured for 24 h with 
GM-CSF+IL-4 (a), GM-CSF+ 
TNF-~t  (b)  or  GM-CSF alone 
(c). The cells were stimulated for 
40 h with LPS or CD40L-J558L. 
IL-12 p40  (empty bars) and p75 
{filled bars) production was mea- 
sured. 
around them makes this source of IL-12 even more effec- 
tive for T  cell stimulation. 
Delespesse  and  coworkers  have  recently  demonstrated 
that monocytes cultured for 48  h  in GM-CSF and IFN-y 
produce low levels oflL-12 (50-100 pg/ml IL-12 p75) af- 
ter stimulation via CD40L  (20).  It is not  clear how  these 
cells relate to fresh monocytes or DCs.  In our experiments 
fresh monocytes produce small amounts  of IL-12 p75  and 
only  when  triggered by  CD40L  and  in  the  presence  of 
IFN-~/. 
It is interesting that DCs  appear to be very selective in 
their capacity to produce IL-12 in response to other stim- 
uli, since they respond only to CD40L.  Indeed other stim- 
uh such as LPS and TNF-~x, which share with CD40L the 
capacity to trigger DCs maturation, are less efficient or in- 
effective in driving IL-12 production by DCs.  In addition, 
Table 1.  DCs  Upregulate MHC  Class II, Adhesion and 
Costimulatory Molecules  after Stimulation  with CD4OL.  TNF-et, 
or LPS 
DQ  ICAM-I  CD80  CD86 
unsdmulated  293  756  125  20 
TNF-~  2060  1595  258  363 
LPS  1634  1726  677  1605 
CD40L  3461  5395  1100  2280 
DCs from  GM-CSF+IL-4-dependent cultures were  stimulated as in 
Fig. 5 and analyzed after 48 h. The data show the median fluorescence 
intensity. The background  (15-30) was subtracted. Comparable results 
were obtained in five separate experiments. 
750  Activation of Dendritic Cells by T Lymphocytes O 
X 
E  e., 
o 
E 
v 
200 
159 
100' 
50 
0. 
10 
10000" 
8000" 
6000. 
4000. 
2000. 
0 
10 
a  r-i  uns  timulat  ed 
￿9  CD40L 
￿9  TNF-u 
100  1000  10000 
DC/well 
,e 
100  1000  lO000 
DC/well 
O 
x 
E 
O 
400 
300 
200 
100 
o; 
10 
8000 
6000 
"~  4000 
E 
--  2000 
10 
C 
._ ......  _  --  ._..  ,  ........  ,  .  .  . 
100  1000  10000 
DC/well' 
d  s 
......../~  -  J~'~-'~-~2~_  ._  . .--,  -.  _  .  .....,  .  .  . 
100  1000  10000 
DC/well 
Figure  5.  The  capacity  of 
DCs to stimulate T cell prolifera- 
tion  and  IFN-"/ production  in 
autologous and aUogeneic MLR. 
is  controlled  by  maturation- 
inducing  stimuli.  DCs  from 
GM-CSF+IL-4  dependent cul- 
tures were stimulated for 40  h 
with LPS ('), TNF-~ (A) or ir- 
radiated CD40L-J558L (O), or 
untreated (I-1) and used as stimu- 
lators in autologous MLIZ (a and 
b) or allogeneic MLIk (c and d). 
T cell proliferation (a and c) and 
IFN-3, production (b and d) were 
measured on day 5. In some cul- 
tures (dotted  line), anti IL-12 anti- 
bodies  were added. DCs  cul- 
tured  with  control J558L cells 
gave results comparable to those 
of  untreated DCs. 
DCs do not produce detectable levels of IL-12 p75  in re- 
sponse to bacteria, which represent a very effective stimulus 
for macrophages. 
Our results indicate that the CD40-CD40L interaction is 
essential  for  triggering  IL-12 production  by DCs,  which 
may be  the  critical  mechanism  for induction  of Thl  re- 
sponses in vivo. Accordingly, the lack of protective T  cell 
responses in CD40L-deficient mice (21)  could well be ex- 
plained by the inability ofT  ceils to trigger IL-12 produc- 
tion  by DCs  with  consequent  failure  to  generate  an  effi- 
cient Thl  response. 
On the  basis  of these  data  the  following scenario  could 
be proposed:  (a) immature DCs scattered in peripheral  tis- 
sues  respond  to  pathogens  or  to  TNF-c~,  produced  as  a 
consequence of tissue  damage,  by maturing and migrating 
to the T  ceil areas of the draining lymph nodes where they 
efficiently present antigen to T  cells;  (b) activated/memory 
T  cells,  that  recognize  antigen  on  DCs,  readily  express 
CD40L and efficiently stimulate  IL-12 production by DCs 
as well as further upregulate DCs adhesion and costimula- 
tory  capacity.  Since  many  T  cells  are  known  to  cluster 
around a single DC, the induction oflL-12 production and 
the upregulation of the stimulatory capacity will result in an 
increased  stimulation  for many  different  T  cells  grouped 
around the same DC. This will result in T-T help via APC 
activation. 
In  this  sequence  of events  the  activation  of APCs  re- 
quires the interaction  of DCs with primed T  ceils  capable 
of expressing  CD40L.  These  may be  present  as  a  conse- 
quence of previous immunizations. Alternatively, DCs stim- 
ulation may be induced by T  ceils  specific for non peptidic 
ligand like some 78+  (22)  or c~/I3+  CD4-  CD8-  T  cells 
(23). 
Our results  suggest  that  immunization  with  a  T  helper 
epitope  might  facilitate  priming  of  CTLs  by  targeting 
CD40L+  Thl  cells  on APCs. This model may explain old 
and new findings in which the generation of specific CTLs 
is  enhanced  by  the  upregulation  of costimulatory  signals 
such as B7 (24). 
Finally, our results are relevant to the therapeutic  use of 
cultured DCs as adjuvants for immunization. The inclusion 
of a universal T  helper epitope (25) may target memory Th 
cells  to  DCs  in  vivo  thus  enhancing  their  capacity  to 
present  and  trigger T  cells  specific for any antigen  that is 
administered simultaneously on the same cells. 
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